Additionally, CatK, which is predominantly extracellularly located, contributes to tumor progression by degrading collagen types I and II, elastin, vascular endothelial factor (VEGF), adiponectin, aggrecan, and osteonectin. The gene discussed is VEGFA; the disease is neoplasm.